Suven Life Sciences Ltd
NSE:SUVEN

Watchlist Manager
Suven Life Sciences Ltd Logo
Suven Life Sciences Ltd
NSE:SUVEN
Watchlist
Price: 117.47 INR -0.53% Market Closed
Market Cap: 25.6B INR
Have any thoughts about
Suven Life Sciences Ltd?
Write Note

Suven Life Sciences Ltd
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Suven Life Sciences Ltd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Suven Life Sciences Ltd
NSE:SUVEN
Free Cash Flow
-â‚ą1.7B
CAGR 3-Years
-8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Free Cash Flow
â‚ą2.6B
CAGR 3-Years
-37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dishman Carbogen Amcis Ltd
NSE:DCAL
Free Cash Flow
â‚ą807.2m
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Free Cash Flow
â‚ą4.7B
CAGR 3-Years
32%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Tarsons Products Ltd
NSE:TARSONS
Free Cash Flow
-â‚ą816.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
Innova Captab Ltd
NSE:INNOVACAP
Free Cash Flow
-â‚ą1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Suven Life Sciences Ltd
Glance View

Market Cap
25.6B INR
Industry
Life Sciences Tools & Services

Suven Life Sciences Ltd. engages on discovering, developing, and commercializing novel pharmaceutical products which are used in classic therapies. The company is headquartered in Hyderabad, Telangana and currently employs 117 full-time employees. The firm is focused on discovering and developing new chemical entities (NCEs), which are central nervous system therapies for the treatment of cognitive disorders, depressive disorders, sleep disorders, psychiatric disorders, pain and inflammation, gastrointestinal motility disorders. Its research targets include serotonin 6 receptor, serotonin 4 receptor, histamine 3 receptor, Nicotinic acetylcholine (Alpha4beta2) receptor, muscarinic M1 receptor, muscarinic M4 receptor, multimodal and P2X purinoceptor 7 receptor. The company provides a range of Drug Discovery and Development Support Services (DDDSS). The firm offers research services specializing in synthetic, medicinal and analytical chemistry, in-vitro assay development and screening, drug metabolism and pharmacokinetics, toxicology and safety pharmacology, bioanalysis, and NCE formulations.

SUVEN Intrinsic Value
2.1 INR
Overvaluation 98%
Intrinsic Value
Price

See Also

What is Suven Life Sciences Ltd's Free Cash Flow?
Free Cash Flow
-1.7B INR

Based on the financial report for Sep 30, 2024, Suven Life Sciences Ltd's Free Cash Flow amounts to -1.7B INR.

What is Suven Life Sciences Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
-8%

Over the last year, the Free Cash Flow growth was -69%. The average annual Free Cash Flow growth rates for Suven Life Sciences Ltd have been -8% over the past three years .

Back to Top